Exosens

Exosens

Global leader in amplification, detection and imaging technologies

Scroll

Exosens markets

See all
Defense & Surveillance

Defense & Surveillance

Innovative and high-quality products that meet the needs of its customers in the fields of defense and surveillance.

Life Sciences & Environment

Life Sciences & Environment

Imaging and detection solutions bring high image quality or low-level detection to enabling Life Sciences breakthroughs.

Industrial Control

Industrial Control

Exosens Technology providing innovative solutions that take control and non-destructive testing to a whole new level.

Nuclear

Nuclear

Nuclear instrumentation is essential to ensure safety, accuracy, and compliance in various nuclear-related activities.

Discover our technologies

See all
See all

What's new?

See all
See all

Our company

Global leader in amplification, detection and imaging technologies

Exosens is a high-tech company, with more than 85 years of experience in the innovation, development, manufacturing and sale of high-end electro-optical technologies in the field of amplification, detection and imaging. Today, it offers its customers detection components and solutions such as advanced cameras, neutron and gamma detectors, instrument detectors and light intensifier tubes. This allows Exosens to respond to complex issues in extremely demanding environments by offering tailor-made solutions to its customers. Thanks to its sustained investments, Exosens is internationally recognized as a major innovator in optoelectronics, with production and R&D carried out on 12 sites, in Europe and North America, and with over 2,000 employees.

Exosens is listed on compartment A of Euronext Paris regulated market (Ticker: EXENS; ISIN: FR001400Q9V2). Exosens is a member of Euronext Tech Leaders segment and is also included in several indices, including SBF 120, CAC All-Tradable, CAC Mid 60, FTSE Total Cap and MSCI France Small Cap. 

More information                Our Innovation

85+ years of experience

+2000 Employees

+300 Proven technology patents

+70 countries: 93% revenue outside France

7.6% of revenue invested in gross R&D

468.2M€ Total revenue